Cargando…

In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells

Human induced pluripotent stem cells (iPSCs) have already been used in transplantation therapies. Currently, cells from healthy people are transplanted into patients with diseases. With the rapid evolution of genome editing technology, genetic modification could be applied to enhance the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Ittetsu, Tsukimura, Takahiro, Ono, Terumi, Shiga, Tomoko, Shitara, Hiroshi, Togawa, Tadayasu, Sakuraba, Hitoshi, Miyaoka, Yuichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186575/ https://www.ncbi.nlm.nih.gov/pubmed/37183961 http://dx.doi.org/10.1177/09636897231173734

Ejemplares similares

Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease
por: Shiga, Tomoko, et al.
Publicado: (2021)

Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy
por: Kubota, Takao, et al.
Publicado: (2022)

Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
por: Tsukimura, Takahiro, et al.
Publicado: (2020)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021)

Fabry disease in a Japanese population-molecular and biochemical characteristics
por: Sakuraba, Hitoshi, et al.
Publicado: (2018)

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor
por: Kanzaki, Minori, et al.
Publicado: (2020)

Cell Transplantation Combined with Recombinant Collagen Peptides for the Treatment of Fabry Disease
por: Kami, Daisuke, et al.
Publicado: (2020)

Genetically Modified Cell Transplantation Through Macroencapsulated Spheroids with Scaffolds to Treat Fabry Disease
por: Kami, Daisuke, et al.
Publicado: (2021)

Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease
por: Sakuraba, Hitoshi, et al.
Publicado: (2015)

Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
por: Tsukimura, Takahiro, et al.
Publicado: (2014)

Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of α-Galactosidase A Protein Levels in Serum and Plasma
por: Nakano, Sachie, et al.
Publicado: (2013)

Impaired Neural Differentiation of Induced Pluripotent Stem Cells Generated from a Mouse Model of Sandhoff Disease
por: Ogawa, Yasuhiro, et al.
Publicado: (2013)

Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review
por: Fujisawa, Hironobu, et al.
Publicado: (2019)

Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy
por: Nakano, Sachie, et al.
Publicado: (2015)

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
por: Kodama, Takashi, et al.
Publicado: (2011)

Erratum to: Screening of Fabry disease in patients with chronic kidney disease in Japan
por: Nagata, Akiko, et al.
Publicado: (2021)

Screening of Fabry disease in patients with chronic kidney disease in Japan
por: Nagata, Akiko, et al.
Publicado: (2021)

FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice
por: Ogawa, Yasuhiro, et al.
Publicado: (2017)

Large-scale single-cell cloning of genome-edited cultured human cells by On-chip SPiS
por: Takahashi, Gou, et al.
Publicado: (2023)

Genome editing is induced in a binary manner in single human cells
por: Takahashi, Gou, et al.
Publicado: (2022)

Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells
por: Riesenberg, Stephan, et al.
Publicado: (2018)

Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells
por: Ma, Xiaojie, et al.
Publicado: (2018)

In Vivo Delivery Systems for Therapeutic Genome Editing
por: Wang, Luyao, et al.
Publicado: (2016)

Gene Editing in Pluripotent Stem Cells and Their Derived Organoids
por: Zhou, Hang, et al.
Publicado: (2021)

Progress and Prospects of Gene Editing in Pluripotent Stem Cells
por: Zhang, Zhenwu, et al.
Publicado: (2023)

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair
por: Kato-Inui, Tomoko, et al.
Publicado: (2018)

Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo
por: Zuris, John A., et al.
Publicado: (2014)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
por: Seah, Yu Fen Samantha, et al.
Publicado: (2015)

Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing
por: Miyaoka, Yuichiro, et al.
Publicado: (2016)

Isolation of single-base genome-edited human iPS cells without antibiotic selection
por: Miyaoka, Yuichiro, et al.
Publicado: (2014)

Gene Editing in Human Pluripotent Stem Cells: Choosing the Correct Path
por: Singh, Amar M., et al.
Publicado: (2015)

Signaling Molecules Governing Pluripotency and Early Lineage Commitments in Human Pluripotent Stem Cells
por: Fathi, Ali, et al.
Publicado: (2017)

Nanoanalysis of the arthropod neuro-toxins
por: Nakajima, Terumi
Publicado: (2006)

Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells
por: Li, Mu, et al.
Publicado: (2022)

Coinhibitory Molecules in Autoimmune Diseases
por: Watanabe, Norihiko, et al.
Publicado: (2012)

PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells
por: Hiramoto, Takafumi, et al.
Publicado: (2023)

To divide or not to divide: revisiting liver regeneration
por: Miyaoka, Yuichiro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h6h4o3tftab9ims389k0q08uuh